[HTML][HTML] Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment

HK Patel, T Bihani - Pharmacology & therapeutics, 2018 - Elsevier
Breast cancer is the most frequently diagnosed cancer in women, with estrogen receptor
positive (ER+) breast cancer making up approximately 75% of all breast cancers diagnosed …

PTEN: multiple functions in human malignant tumors

M Milella, I Falcone, F Conciatori, U Cesta Incani… - Frontiers in …, 2015 - frontiersin.org
PTEN is the most important negative regulator of the PI3K signaling pathway. In addition to
its canonical, PI3K inhibition-dependent functions, PTEN can also function as a tumor …

Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer

YM Wu, M Cieślik, RJ Lonigro, P Vats, MA Reimers… - Cell, 2018 - cell.com
Using integrative genomic analysis of 360 metastatic castration-resistant prostate cancer
(mCRPC) samples, we identified a novel subtype of prostate cancer typified by biallelic loss …

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Y Xing, NU Lin, MA Maurer, H Chen, A Mahvash… - Breast Cancer …, 2019 - Springer
Abstract Background The PI3K/AKT pathway is activated through PIK3CA or AKT1 mutations
and PTEN loss in breast cancer. We conducted a phase II trial with an allosteric AKT …

The importance of breast adipose tissue in breast cancer

C Kothari, C Diorio, F Durocher - International journal of molecular …, 2020 - mdpi.com
Adipose tissue is a complex endocrine organ, with a role in obesity and cancer. Adipose
tissue is generally linked to excessive body fat, and it is well known that the female breast is …

Targeting PI3K/AKT/mTOR signaling pathway in breast cancer

H Li, L Prever, E Hirsch, F Gulluni - Cancers, 2021 - mdpi.com
Simple Summary PI3K signaling pathway plays an essential role in many cellular processes
and is frequently altered in breast cancer, leading to increased tumor growth and reduced …

Cancer transcriptome profiling at the juncture of clinical translation

M Cieślik, AM Chinnaiyan - Nature Reviews Genetics, 2018 - nature.com
Methodological breakthroughs over the past four decades have repeatedly revolutionized
transcriptome profiling. Using RNA sequencing (RNA-seq), it has now become possible to …

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi… - PloS one, 2013 - journals.plos.org
Purpose Clinicopathologic features and biochemical recurrence are sensitive, but not
specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a …

CD63+ Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22

Y Gao, X Li, C Zeng, C Liu, Q Hao, W Li… - Advanced …, 2020 - Wiley Online Library
Tamoxifen remains the most effective treatment for estrogen receptor α (ERα)‐positive
breast cancer. However, many patients still develop resistance to tamoxifen in association …

[HTML][HTML] Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

BS Carver, C Chapinski, J Wongvipat, H Hieronymus… - Cancer cell, 2011 - cell.com
Prostate cancer is characterized by its dependence on androgen receptor (AR) and frequent
activation of PI3K signaling. We find that AR transcriptional output is decreased in human …